Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C18H26N2O4S |
| Molecular Weight | 366.475 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=C(C=C1)S(=O)(=O)NC(=O)N[C@@H]2[C@H](O)[C@]3(C)CC[C@H]2C3(C)C
InChI
InChIKey=RMTYNAPTNBJHQI-LLDVTBCESA-N
InChI=1S/C18H26N2O4S/c1-11-5-7-12(8-6-11)25(23,24)20-16(22)19-14-13-9-10-18(4,15(14)21)17(13,2)3/h5-8,13-15,21H,9-10H2,1-4H3,(H2,19,20,22)/t13-,14+,15+,18+/m1/s1
| Molecular Formula | C18H26N2O4S |
| Molecular Weight | 366.475 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://medikamio.com/de-ch/medikamente/glutril/pil
Sources: https://medikamio.com/de-ch/medikamente/glutril/pil
Glibornuride is sulphonylurea derivative used as an oral hypoglycemic drug in patients with diabetes. The drug was marketed under the name Glutril, however, it is no longer available.
Originator
Sources: https://www.google.com/patents/US3654357
Curator's Comment: # Hoffmann La Roche
Approval Year
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
18.5 μg × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/3157397/ |
25 mg single, intravenous dose: 25 mg route of administration: Intravenous experiment type: SINGLE co-administered: |
GLIBORNURIDE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
9.2 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/3157397/ |
25 mg single, intravenous dose: 25 mg route of administration: Intravenous experiment type: SINGLE co-administered: |
GLIBORNURIDE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis. | 2008-11 |
|
| Effects of parsley (Petroselinum crispum) extract versus glibornuride on the liver of streptozotocin-induced diabetic rats. | 2006-03-08 |
|
| Effects of glibornuride versus metformin on eye lenses and skin in experimental diabetes. | 2006 |
|
| Identification and quantification of 8 sulfonylureas with clinical toxicology interest by liquid chromatography-ion-trap tandem mass spectrometry and library searching. | 2005-09 |
|
| The morphological and biochemical effects of glibornuride on rat liver in experimental diabetes. | 2004-05 |
|
| Screening, library-assisted identification and validated quantification of oral antidiabetics of the sulfonylurea-type in plasma by atmospheric pressure chemical ionization liquid chromatography-mass spectrometry. | 2002-06-15 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://medikamio.com/de-ch/medikamente/glutril/pil
The recommended dose is 0.5 tablet (1 tablet contains 25 mg of glibornuride) per day, given at breakfast time. Do not take more than 3 tablets per day.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:53:02 GMT 2025
by
admin
on
Mon Mar 31 17:53:02 GMT 2025
|
| Record UNII |
VP83E7434R
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QA10BB04
Created by
admin on Mon Mar 31 17:53:02 GMT 2025 , Edited by admin on Mon Mar 31 17:53:02 GMT 2025
|
||
|
WHO-ATC |
A10BB04
Created by
admin on Mon Mar 31 17:53:02 GMT 2025 , Edited by admin on Mon Mar 31 17:53:02 GMT 2025
|
||
|
NCI_THESAURUS |
C97936
Created by
admin on Mon Mar 31 17:53:02 GMT 2025 , Edited by admin on Mon Mar 31 17:53:02 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
VP83E7434R
Created by
admin on Mon Mar 31 17:53:02 GMT 2025 , Edited by admin on Mon Mar 31 17:53:02 GMT 2025
|
PRIMARY | |||
|
C123430
Created by
admin on Mon Mar 31 17:53:02 GMT 2025 , Edited by admin on Mon Mar 31 17:53:02 GMT 2025
|
PRIMARY | |||
|
26944-48-9
Created by
admin on Mon Mar 31 17:53:02 GMT 2025 , Edited by admin on Mon Mar 31 17:53:02 GMT 2025
|
PRIMARY | |||
|
DTXSID001016937
Created by
admin on Mon Mar 31 17:53:02 GMT 2025 , Edited by admin on Mon Mar 31 17:53:02 GMT 2025
|
PRIMARY | |||
|
1298
Created by
admin on Mon Mar 31 17:53:02 GMT 2025 , Edited by admin on Mon Mar 31 17:53:02 GMT 2025
|
PRIMARY | |||
|
2751
Created by
admin on Mon Mar 31 17:53:02 GMT 2025 , Edited by admin on Mon Mar 31 17:53:02 GMT 2025
|
PRIMARY | |||
|
100000080423
Created by
admin on Mon Mar 31 17:53:02 GMT 2025 , Edited by admin on Mon Mar 31 17:53:02 GMT 2025
|
PRIMARY | |||
|
C073323
Created by
admin on Mon Mar 31 17:53:02 GMT 2025 , Edited by admin on Mon Mar 31 17:53:02 GMT 2025
|
PRIMARY | |||
|
DB08962
Created by
admin on Mon Mar 31 17:53:02 GMT 2025 , Edited by admin on Mon Mar 31 17:53:02 GMT 2025
|
PRIMARY | |||
|
102846
Created by
admin on Mon Mar 31 17:53:02 GMT 2025 , Edited by admin on Mon Mar 31 17:53:02 GMT 2025
|
PRIMARY | RxNorm | ||
|
GLIBORNURIDE
Created by
admin on Mon Mar 31 17:53:02 GMT 2025 , Edited by admin on Mon Mar 31 17:53:02 GMT 2025
|
PRIMARY | |||
|
248-124-6
Created by
admin on Mon Mar 31 17:53:02 GMT 2025 , Edited by admin on Mon Mar 31 17:53:02 GMT 2025
|
PRIMARY | |||
|
12818200
Created by
admin on Mon Mar 31 17:53:02 GMT 2025 , Edited by admin on Mon Mar 31 17:53:02 GMT 2025
|
PRIMARY | |||
|
CHEMBL529888
Created by
admin on Mon Mar 31 17:53:02 GMT 2025 , Edited by admin on Mon Mar 31 17:53:02 GMT 2025
|
PRIMARY | |||
|
SUB07917MIG
Created by
admin on Mon Mar 31 17:53:02 GMT 2025 , Edited by admin on Mon Mar 31 17:53:02 GMT 2025
|
PRIMARY | |||
|
m5743
Created by
admin on Mon Mar 31 17:53:02 GMT 2025 , Edited by admin on Mon Mar 31 17:53:02 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |